Latest News

Crystal Pharmatech Completes ELDICO ED-1 Installation; Dedicated MicroED Now in Routine Service

Instrument operational at the Suzhou R&D center, with MicroED built into solid-form screening and results in as little as 48 hours SUZHOU, China, Nov. 4, 2026 /PRNewswire/ -- Crystal Pharmatech, a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulati...

2026-11-04 20:15

Zetaris equips partners to reduce data friction for enterprise AI

AI Data Harness connects governed enterprise data while new program equips technology partners, SIs, and service providers to build and deliver solutions on the Zetaris AI Data Harness SAN FRANCISCO, Nov. 4, 2026 /PRNewswire/ -- Zetaris today announced the launch of their new Zetaris Partner Pro...

2026-11-04 20:09

CL Workshop Group Limited Announces Plan to Implement ADS Ratio Change

HONG KONG, Nov. 4, 2026 /PRNewswire/ -- CL Workshop Group Limited (NASDAQ: NWGL) (the "Company"), a global forestry company that focuses on the timber and wood products industry, today announced that it will change the ratio (the "ADS Ratio") of its American Depositary Shares ("ADSs") to Class A ...

2026-11-04 19:05 158

Salomon Trail Week Concludes with Global Elites at Tsaigu, Bringing Chinese Trail Running Closer to the World

LINHAI, China, Nov. 4, 2026 /PRNewswire/ -- Salomon Trail Week wrapped up with a standout showing at the Tsaigu Trail race in the Kuocang Mountains, capping a week of racing and community events organized by the French outdoor sports brand. The race brought together 6,500 runners, including 20 Ch...

2026-11-04 18:21 720

ZKH Group Limited to Announce Third Quarter 2026 Financial Results on Wednesday, November 18, 2026

SHANGHAI, Nov. 4, 2026 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform in China, today announced that it will release its unaudited financial results for the third quarter 2026, on Wednesday,...

2026-11-04 18:00 385

TJ Biopharma Announces Publication of Plonmarlimab Phase 2 Results in the Journal of Hematology & Oncology

* Findings build on TJ Biopharma's pioneering work on GM-CSF as a therapeutic target in macrophage- and myeloid cell-driven inflammation * Phase 2 results show encouraging clinical responses and glucocorticoid-sparing potential in macrophage activation syndrome HANGZHOU, China, Nov. 4, 2026 /...

2026-11-04 18:00 780

Autohome Inc. Announces Unaudited Third Quarter 2026 Financial Results

BEIJING, Nov. 4, 2026 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers in China, today announced its unaudited financial results for the three months ended September 30, 2026. Third Quarter 2026 Highligh...

2026-11-04 17:30 692

NUHS, SINGTEL AND ERICSSON EXPAND PARTNERSHIP TO ADVANCE NEXT-GENERATION CONNECTED HEALTHCARE

Extended collaboration will accelerate research and development in advanced connectivity and emerging 5G Advanced & future 6G technologies for Healthcare of the Future. SINGAPORE, Nov. 3, 2026 /PRNewswire/ -- The National University Health System (NUHS), Singtel and Ericsson today signed a Memor...

2026-11-04 15:47 705

Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Third Quarter of 2026

TAIPEI, Nov. 4, 2026 /PRNewswire/ -- Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) ("Chunghwa" or "the Company") today reported its un-audited operating results for the third quarter of 2026. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards ("T...

2026-11-04 15:46 674

Minghui Pharmaceutical and ASKA Pharmaceutical Enter into Exclusive License Agreement for the IGF-1R Antibody in Japan

HANGZHOU, China, SHANGHAI and TOKYO, Nov. 4, 2026 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui") and ASKA PharmaceuticalCo., Ltd. ("ASKA") today announced that they have entered into an exclusive license agreement for the development and commercialization of MHB018A in Japan. MHB018A is a no...

2026-11-04 14:30 1764

New Era for School STEM: Cosmofluencer Launches CosmoClub with Fizzics Education's India Entry

BENGALURU, India, Nov. 4, 2026 /PRNewswire/ -- Cosmofluencer, the astronomy outreach and SciComm arm of Centelon Group, has announced a strategic partnership with award-winning Australian science-education provider Fizzics Education as it enters India. Building on this collaboration, Cosmofluenc...

2026-11-04 13:53 596

IASO Bio Hosts FUCASO Singapore Launch Event, Marking the Official Commercial Landing of China's Original Fully Human BCMA CAR-T Cell Therapy in Southeast Asia's Healthcare Hub

IASO Bio and its Singapore partner Pills and Pokes jointly hosted the FUCASO launch event in Singapore on November 3, marking the official commercial arrival of the world's first fully human BCMA-targeted CAR-T cell therapy in Singapore. FUCASO was approved by Singapore's Health Sciences Authorit...

2026-11-04 12:59 1179

WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence

HONG KONG, Nov. 3, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced it received two Grand Awards at the ninth Hong Kong ESG Reporting Awards (HERA), winning Best ESG Report (Large-Cap) and Excell...

2026-11-04 12:44 741

Wenge AI Subsidiary D2 Intelligence Showcases Four AI Products at Hong Kong FinTech Week 2026

HONG KONG, Nov. 3, 2026 /PRNewswire/ -- D2 Intelligence, a subsidiary of Wenge AI (1956.HK), is showcasing at Hong Kong FinTech Week x StartmeupHK 2026. Under this year's theme "Fintech Nexus: Bridging the World, Building the Future", Asia's flagshipfintech event brought together more than 45,000...

2026-11-04 10:30 875

Samsung Biologics Achieves 'Negligible Risk' Rating in Sustainalytics ESG Assessment

* Earns ESG Risk Rating score of 9.0, ranking among the top 0.5% in the pharmaceuticals industry * Advances from 'Low Risk' to 'Negligible Risk,' the lowest ESG risk category * Recognition reflects continued improvements in ESG risk management across operations INCHEON, South Korea, Nov. 3, ...

2026-11-04 07:30 1689

Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition

The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across China HANGZHOU, China, Nov. 3, 2026 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutions company in Asia, announced the strategic acqu...

2026-11-04 07:00 1314

YYForce Launches New Corporate Website Showcasing Its Unified AI and Robotics Ecosystem

YYForce sets out how flexible workforce solutions, 24iFM estate management, and commercial robotics work together to modernize frontline operations and facilities management SINGAPORE, Nov. 3, 2026 /PRNewswire/ -- YYForce Inc. (Nasdaq: YFOR) ("YYForce" or the "Company"), a technology-enabled pro...

2026-11-04 05:10 1296

Robo.ai Inc. Reaffirms the Upcoming Reverse Stock Split

DUBAI, UAE, Nov. 3, 2026 /PRNewswire/ -- Robo.ai Inc. (Nasdaq: AIIO) (the "Company"), a UAE-based, U.S.-listed technology company, today reaffirmed its previously announced and approved 1-for-25 reverse stock split of all classes of the Company's ordinary shares, including the Class A ordinary sh...

2026-11-04 05:04 1557

HBADA Launches E3 Ultra Ergonomic Chair with Full-Body Tracking Support and Heated Bionic Massage

LOS ANGELES, Nov. 3, 2026 /PRNewswire/ -- HBADA, an innovator in professional ergonomic seating solutions, officially announced the launch of its fifth-generation flagship product, theHBADA E3 Ultra Ergonomic Office Chair

2026-11-03 23:00 2859

MoleculeMind's New MMDesign Technical Report Demonstrates 94.7% Campaign Success Rate Across Diverse Molecular Targets and Modalities

SHANGHAI, Nov. 3, 2026 /PRNewswire/ -- MoleculeMind , an AI-nativebiological infrastructure company, recently released a new technical report detailing the performance of MMDesign, its AI-powered de novo molecular design platform which demonstrated a94.7% campaign succes...

2026-11-03 23:00 5201
12345 ... 1725